Stock Fundamentals

Company Information

Company Name
Nuvectis Pharma Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US67080T1088
CIK: 0001875558
CUSIP: 67080T108
Currency: USD
Full Time Employees: 12
Phone: 201 614 3150
Fiscal Year End: December
IPO Date: Feb 04, 2022
Description:

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

Address:

1 Bridge Plaza, Fort Lee, NJ, United States, 07024

Directors & Officers

Name Title Year Born
Mr. Ron Bentsur M.B.A. Co-Founder, Chairman, CEO & President 1966
Dr. Enrique Poradosu Ph.D. Co-Founder, Executive VP, Chief Scientific & Business Officer 1967
Mr. Shay Shemesh Co-Founder, Executive VP, Chief Development & Operations Officer 1984
Mr. Michael Carson CPA Vice President of Finance 1976

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 05, 2025 Juan Sanchez N/A Purchase 13.00K $5.79 $75.27K
Nov 05, 2025 Matthew L Kaplan N/A Purchase 11.00K $5.84 $64.24K
Nov 05, 2025 Ron Bentsur N/A Purchase 5.00K $5.72 $28.60K
Oct 27, 2025 Marlio Charles Mosseri N/A Purchase 72.84K $6.28 $457.41K
Oct 24, 2025 Marlio Charles Mosseri N/A Purchase 35.03K $6.15 $215.46K
Oct 23, 2025 Marlio Charles Mosseri N/A Purchase 46.90K $6.06 $284.21K
Jun 20, 2025 Marlio Charles Mosseri N/A Purchase 5.60K $7.99 $44.77K
Jun 18, 2025 Marlio Charles Mosseri N/A Purchase 28.04K $8.05 $225.75K
Jun 17, 2025 Marlio Charles Mosseri N/A Purchase 5.40K $8.11 $43.79K
May 12, 2025 Marlio Charles Mosseri N/A Purchase 21.17K $8.11 $171.66K
May 08, 2025 Marlio Charles Mosseri N/A Purchase 2.65K $8.65 $22.92K
May 06, 2025 Marlio Charles Mosseri N/A Purchase 12.44K $8.59 $106.89K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 845.50K Dec 31, 2025 3.19% $0.00 21.01%
BlackRock Inc 764.44K Mar 31, 2026 2.88% $0.00 -2.35%
Vanguard Capital Management, LLC 659.88K Mar 31, 2026 2.49% $0.00 0.00%
Iridian Asset Management LLC 651.76K Mar 31, 2026 2.46% $2.04 11.16%
Occam Crest Management L.P. 407.15K Mar 31, 2026 1.53% $1.91 7.14%
Geode Capital Management, LLC 384.11K Mar 31, 2026 1.45% $0.00 5.52%
Baldwin Brothers Inc 378.63K Mar 31, 2026 1.43% $0.21 -2.82%
State Street Corp 166.52K Mar 31, 2026 0.63% $0.00 7.66%
Northern Trust Corp 124.21K Mar 31, 2026 0.47% $0.00 6.71%
Vanguard Fiduciary Trust Co 114.84K Mar 31, 2026 0.43% $0.00 0.00%
Susquehanna International Group, LLP 105.29K Mar 31, 2026 0.40% $0.00 -21.52%
Vanguard Portfolio Management, LLC 92.15K Mar 31, 2026 0.35% $0.00 0.00%
Citadel Advisors Llc 78.43K Mar 31, 2026 0.30% $0.00 0.00%
Oppenheimer & Co Inc 73.57K Mar 31, 2026 0.28% $0.01 0.00%
Forbes J M & Co 59.00K Mar 31, 2026 0.22% $0.04 0.00%
Charles Schwab Investment Management Inc 49.65K Mar 31, 2026 0.19% $0.00 12.77%
The Goldman Sachs Group Inc 41.12K Mar 31, 2026 0.16% $0.00 55.17%
UBS Group AG 38.56K Mar 31, 2026 0.15% $0.00 360.45%
Bank of New York Mellon Corp 30.32K Mar 31, 2026 0.11% $0.00 -4.17%
Marshall Wace Asset Management Ltd 29.22K Mar 31, 2026 0.11% $0.00 0.00%

Shares Statistics

Shares Outstanding: 31.53M
Shares Float: 16.98M
% Insiders: 3,549.10%
% Institutions: 1,442.00%
Short % Float: 11.56%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 439.69K 1.66% ▲ 0.00% Apr 30, 2026
2 iShares Russell 2000 ETF 347.55K 1.31% ▲ 0.94% May 29, 2026
3 Vanguard Institutional Extnd Mkt Idx Tr 209.89K 0.79% ▲ 0.00% Apr 30, 2026
4 Fidelity Small Cap Index 151.02K 0.57% ▲ 0.44% Mar 31, 2026
5 iShares Russell 2000 Growth ETF 124.15K 0.47% ▼ 0.65% May 29, 2026
6 Fidelity Extended Market Index 93.30K 0.35% ▼ 0.36% Apr 30, 2026
7 Russell 2000 Equity Index Fund B 78.54K 0.30% ▲ 0.15% Dec 31, 2025
8 Vanguard Russell 2000 ETF 77.94K 0.29% ▲ 2.09% Apr 30, 2026
9 State St Russell Sm Cap® Idx SL Cl I 47.10K 0.18% ▲ 0.00% May 31, 2026
10 iShares Micro-Cap ETF 40.01K 0.15% ▲ 0.00% May 29, 2026

Valuation Metrics

Enterprise Value: $554.94M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $578.49M
Book Value: $0.54
Earnings/Share: $-1.31
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -63.61%
ROE (TTM): -154.43%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 2.38x 0.00x 0.42x N/A 0.00x
2024-12-31 2.09x 0.00x 0.48x N/A 0.00x
2023-12-31 2.75x 0.00x 0.36x N/A 0.00x
2022-12-31 3.30x 0.00x 0.30x -129.09x 0.00x
2021-12-31 2.41x 0.00x 2.65x -3,223.50x 0.00x
2020-12-31 583.30x 0.00x 0.00x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about NVCT.US!